The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma

Kathrine T. Isaksen; Klaus Beiske; Erlend B. Smeland; Judit Jørgensen; Marianne Brodtkorb; June Helen Myklebust; Mats Jerkeman; Leo Meriranta; Marja-Liisa Karjalainen-Lindsberg; Sirpa Leppä; David W. Scott; Harald Holte; Yngvild Nuvin Blaker

doi:10.1002/jha2.109

The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma

Kathrine T. Isaksen, Klaus Beiske, Erlend B. Smeland, Judit Jørgensen, Marianne Brodtkorb, June Helen Myklebust, Mats Jerkeman, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg, Sirpa Leppä, David W. Scott, Harald Holte, Yngvild Nuvin Blaker

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	eJHaem
Vuosikerta	2
Numero	1
Sivut	104-108
Sivumäärä	5
DOI - pysyväislinkit	https://doi.org/10.1002/jha2.109
Tila	Julkaistu - 2021
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3122 Syöpätaudit

Pääsy asiakirjaan

10.1002/jha2.109Lisenssi: CC BY

eJHaem - 2020 - Isaksen - The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity inLopullinen julkaistu versio, 222 KBLisenssi: CC BY

Siteeraa tätä

Isaksen, K. T., Beiske, K., Smeland, E. B., Jørgensen, J., Brodtkorb, M., Myklebust, J. H., Jerkeman, M., Meriranta, L., Karjalainen-Lindsberg, M-L., Leppä, S., Scott, D. W., Holte, H., & Blaker, Y. N. (2021). The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma. eJHaem, 2(1), 104-108. https://doi.org/10.1002/jha2.109

@article{eac6bc9e51be4bcf89e6c7345907fc50,

title = "The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma",

keywords = "3122 Cancers",

author = "Isaksen, {Kathrine T.} and Klaus Beiske and Smeland, {Erlend B.} and Judit J{\o}rgensen and Marianne Brodtkorb and Myklebust, {June Helen} and Mats Jerkeman and Leo Meriranta and Marja-Liisa Karjalainen-Lindsberg and Sirpa Lepp{\"a} and Scott, {David W.} and Harald Holte and Blaker, {Yngvild Nuvin}",

year = "2021",

doi = "10.1002/jha2.109",

language = "English",

volume = "2",

pages = "104--108",

journal = "eJHaem",

issn = "2688-6146",

publisher = "John Wiley & Sons Ltd. ",

number = "1",

}

Isaksen, KT, Beiske, K, Smeland, EB, Jørgensen, J, Brodtkorb, M, Myklebust, JH, Jerkeman, M, Meriranta, L , Karjalainen-Lindsberg, M-L , Leppä, S, Scott, DW, Holte, H & Blaker, YN 2021, 'The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma', eJHaem, Vuosikerta 2, Nro 1, Sivut 104-108. https://doi.org/10.1002/jha2.109

The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma. / Isaksen, Kathrine T.; Beiske, Klaus; Smeland, Erlend B. et al.

julkaisussa: eJHaem, Vuosikerta 2, Nro 1, 2021, s. 104-108.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma

AU - Isaksen, Kathrine T.

AU - Beiske, Klaus

AU - Smeland, Erlend B.

AU - Jørgensen, Judit

AU - Brodtkorb, Marianne

AU - Myklebust, June Helen

AU - Jerkeman, Mats

AU - Meriranta, Leo

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Leppä, Sirpa

AU - Scott, David W.

AU - Holte, Harald

AU - Blaker, Yngvild Nuvin

PY - 2021

Y1 - 2021

KW - 3122 Cancers

U2 - 10.1002/jha2.109

DO - 10.1002/jha2.109

M3 - Article

VL - 2

SP - 104

EP - 108

JO - eJHaem

JF - eJHaem

SN - 2688-6146

IS - 1

ER -